Biosig Technologies Inc (NASDAQ:BSGM) does about 373.59K shares in volume on a normal day but saw 2707560 shares change hands in the recent trading day. The company now has a market cap of 35.17M USD. Its current market price is $1.45, marking an increase of 5.84% compared to the previous close of $1.37. The 52 week high reached by this stock is $2.57 whilst the lowest price level in 52 weeks is $0.20. The script in recent trading has seen the stock touch a high of $0.41 and a low of $0.41.
Biosig Technologies Inc (BSGM) has a 20-day trading average at $0.7880 and the current price is -43.58% off the 52-week high compared with 621.39% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7458 and its 200-day simple moving average is $0.8731. If we look at the stock’s price movements over the week, volatility stands at 20.71%, which increases to 22.30% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 78.01 to suggest the stock is overbought.
The consensus objective for the share price is $2.50, suggesting that the stock has a potential upside of 42.0% over the period. The median price target is -253.66% away from the current levels at $0.41.
The current price level is 84.04%, 94.43%, and 66.07% away from its SMA20, SMA50, and SMA200 respectively, with the BSGM price moving below the 50-day SMA on current market day. Biosig Technologies Inc (BSGM) stock is up 39.42% over the week and 187.13% over the past month. Its price is -2.68% year-to-date and -27.14% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.05 and -0.2 for whole year.
Its 12-month price target is $0.41. To reach the target analysts have set, the stock logically needs to grow 42.0 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $0.41, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $0.41.
Outstanding shares total 17.24M with insiders holding 14.80% of the shares and institutional holders owning 21.17% of the company’s common stock. The company has a return on equity of -8041.70%. The beta has a value of -0.02. Price to sales ratio is 879.25.
